Effect of Trans-2,3-dimethoxycinnamoyl azide on enhancing antitumor activity of romidepsin on human bladder cancer

Clinical Cancer Research

Volumn 14, Issue 4, 2008, Pages 1200-1207

  Fan, Jinhai ^a,b   Stanfield, Jennifer ^a   Guo, Yi ^a   Karam, Jose A ^a   Frenkel, Eugene ^a   Sun, Xiankai ^a   Hsieh, Jer Tsong ^a,c  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIMETHOXYCINNAMOYL AZIDE; AZIDE; HISTONE DEACETYLASE; ROMIDEPSIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER MODEL; CELL CYCLE ARREST; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG PURIFICATION; DRUG PURITY; DRUG SCREENING; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; MONOTHERAPY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALS; ANTHRANILIC ACIDS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; AZIDES; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; CINNAMATES; DEPSIPEPTIDES; ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS; MICE; MICE, NUDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; URINARY BLADDER NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 39749131015     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1656     Document Type: Article

References (33)